nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Liver fatty—Octreotide—thymus cancer	0.0629	0.0629	CcSEcCtD
Sibutramine—Thyroid disorder—Octreotide—thymus cancer	0.0481	0.0481	CcSEcCtD
Sibutramine—Abnormal faeces—Octreotide—thymus cancer	0.0276	0.0276	CcSEcCtD
Sibutramine—Hepatic steatosis—Octreotide—thymus cancer	0.0261	0.0261	CcSEcCtD
Sibutramine—Goitre—Octreotide—thymus cancer	0.0221	0.0221	CcSEcCtD
Sibutramine—Varicose vein—Octreotide—thymus cancer	0.0212	0.0212	CcSEcCtD
Sibutramine—VIIth nerve paralysis—Octreotide—thymus cancer	0.0192	0.0192	CcSEcCtD
Sibutramine—Intraocular pressure increased—Octreotide—thymus cancer	0.0179	0.0179	CcSEcCtD
Sibutramine—Hernia—Octreotide—thymus cancer	0.0168	0.0168	CcSEcCtD
Sibutramine—Rectal disorder—Octreotide—thymus cancer	0.0161	0.0161	CcSEcCtD
Sibutramine—Anorectal disorder—Octreotide—thymus cancer	0.015	0.015	CcSEcCtD
Sibutramine—Ear disorder—Octreotide—thymus cancer	0.0146	0.0146	CcSEcCtD
Sibutramine—Cholecystitis—Octreotide—thymus cancer	0.0137	0.0137	CcSEcCtD
Sibutramine—Haemorrhoids—Octreotide—thymus cancer	0.0134	0.0134	CcSEcCtD
Sibutramine—Cholelithiasis—Octreotide—thymus cancer	0.0127	0.0127	CcSEcCtD
Sibutramine—Hypothyroidism—Octreotide—thymus cancer	0.0123	0.0123	CcSEcCtD
Sibutramine—Nail disorder—Octreotide—thymus cancer	0.0122	0.0122	CcSEcCtD
Sibutramine—Intestinal obstruction—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Sibutramine—Menstrual disorder—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Sibutramine—Neuralgia—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Sibutramine—Metrorrhagia—Octreotide—thymus cancer	0.011	0.011	CcSEcCtD
Sibutramine—Neuritis—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Sibutramine—Herpes zoster—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Sibutramine—Otitis media—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Sibutramine—Petechiae—Octreotide—thymus cancer	0.00959	0.00959	CcSEcCtD
Sibutramine—Acne—Octreotide—thymus cancer	0.00938	0.00938	CcSEcCtD
Sibutramine—Neoplasm malignant—Octreotide—thymus cancer	0.00924	0.00924	CcSEcCtD
Sibutramine—Contusion—Octreotide—thymus cancer	0.00904	0.00904	CcSEcCtD
Sibutramine—Amenorrhoea—Octreotide—thymus cancer	0.00898	0.00898	CcSEcCtD
Sibutramine—Rectal haemorrhage—Octreotide—thymus cancer	0.00873	0.00873	CcSEcCtD
Sibutramine—Cellulitis—Octreotide—thymus cancer	0.00868	0.00868	CcSEcCtD
Sibutramine—Arthropathy—Octreotide—thymus cancer	0.00868	0.00868	CcSEcCtD
Sibutramine—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00868	0.00868	CcSEcCtD
Sibutramine—Herpes simplex—Octreotide—thymus cancer	0.00856	0.00856	CcSEcCtD
Sibutramine—Muscle twitching—Octreotide—thymus cancer	0.00803	0.00803	CcSEcCtD
Sibutramine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00789	0.00789	CcSEcCtD
Sibutramine—Hyperkalaemia—Octreotide—thymus cancer	0.00775	0.00775	CcSEcCtD
Sibutramine—Eructation—Octreotide—thymus cancer	0.00775	0.00775	CcSEcCtD
Sibutramine—Cystitis noninfective—Octreotide—thymus cancer	0.00771	0.00771	CcSEcCtD
Sibutramine—Cystitis—Octreotide—thymus cancer	0.00762	0.00762	CcSEcCtD
Sibutramine—Cramps of lower extremities—Octreotide—thymus cancer	0.00725	0.00725	CcSEcCtD
Sibutramine—Mouth ulceration—Octreotide—thymus cancer	0.00713	0.00713	CcSEcCtD
Sibutramine—Bladder pain—Octreotide—thymus cancer	0.00713	0.00713	CcSEcCtD
Sibutramine—Hyperkinesia—Octreotide—thymus cancer	0.00688	0.00688	CcSEcCtD
Sibutramine—Phlebitis—Octreotide—thymus cancer	0.00665	0.00665	CcSEcCtD
Sibutramine—Sleep disorder—Octreotide—thymus cancer	0.00662	0.00662	CcSEcCtD
Sibutramine—Diabetes mellitus—Octreotide—thymus cancer	0.00658	0.00658	CcSEcCtD
Sibutramine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00658	0.00658	CcSEcCtD
Sibutramine—Gastroenteritis—Octreotide—thymus cancer	0.00646	0.00646	CcSEcCtD
Sibutramine—Cardiac failure congestive—Octreotide—thymus cancer	0.00632	0.00632	CcSEcCtD
Sibutramine—Nasal congestion—Octreotide—thymus cancer	0.00629	0.00629	CcSEcCtD
Sibutramine—Injury—Octreotide—thymus cancer	0.00623	0.00623	CcSEcCtD
Sibutramine—Amnesia—Octreotide—thymus cancer	0.0061	0.0061	CcSEcCtD
Sibutramine—Anaphylactoid reaction—Octreotide—thymus cancer	0.00592	0.00592	CcSEcCtD
Sibutramine—Arthritis—Octreotide—thymus cancer	0.00589	0.00589	CcSEcCtD
Sibutramine—Hypoglycaemia—Octreotide—thymus cancer	0.00587	0.00587	CcSEcCtD
Sibutramine—Pain in extremity—Octreotide—thymus cancer	0.00573	0.00573	CcSEcCtD
Sibutramine—Osteoarthritis—Octreotide—thymus cancer	0.00573	0.00573	CcSEcCtD
Sibutramine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00573	0.00573	CcSEcCtD
Sibutramine—Psychotic disorder—Octreotide—thymus cancer	0.00559	0.00559	CcSEcCtD
Sibutramine—Dehydration—Octreotide—thymus cancer	0.00533	0.00533	CcSEcCtD
Sibutramine—Dry skin—Octreotide—thymus cancer	0.00525	0.00525	CcSEcCtD
Sibutramine—Gastritis—Octreotide—thymus cancer	0.00507	0.00507	CcSEcCtD
Sibutramine—Muscular weakness—Octreotide—thymus cancer	0.00505	0.00505	CcSEcCtD
Sibutramine—Abdominal distension—Octreotide—thymus cancer	0.00498	0.00498	CcSEcCtD
Sibutramine—Influenza—Octreotide—thymus cancer	0.00495	0.00495	CcSEcCtD
Sibutramine—Asthma—Octreotide—thymus cancer	0.00495	0.00495	CcSEcCtD
Sibutramine—Bronchitis—Octreotide—thymus cancer	0.00476	0.00476	CcSEcCtD
Sibutramine—Dysuria—Octreotide—thymus cancer	0.00463	0.00463	CcSEcCtD
Sibutramine—Pollakiuria—Octreotide—thymus cancer	0.00457	0.00457	CcSEcCtD
Sibutramine—Weight increased—Octreotide—thymus cancer	0.0045	0.0045	CcSEcCtD
Sibutramine—Hyperglycaemia—Octreotide—thymus cancer	0.00447	0.00447	CcSEcCtD
Sibutramine—Pneumonia—Octreotide—thymus cancer	0.00444	0.00444	CcSEcCtD
Sibutramine—Depression—Octreotide—thymus cancer	0.0044	0.0044	CcSEcCtD
Sibutramine—Neuropathy peripheral—Octreotide—thymus cancer	0.00433	0.00433	CcSEcCtD
Sibutramine—Urinary tract infection—Octreotide—thymus cancer	0.00429	0.00429	CcSEcCtD
Sibutramine—Conjunctivitis—Octreotide—thymus cancer	0.00429	0.00429	CcSEcCtD
Sibutramine—Haematuria—Octreotide—thymus cancer	0.00421	0.00421	CcSEcCtD
Sibutramine—Epistaxis—Octreotide—thymus cancer	0.00416	0.00416	CcSEcCtD
Sibutramine—Sinusitis—Octreotide—thymus cancer	0.00414	0.00414	CcSEcCtD
Sibutramine—Bradycardia—Octreotide—thymus cancer	0.00403	0.00403	CcSEcCtD
Sibutramine—Rhinitis—Octreotide—thymus cancer	0.00397	0.00397	CcSEcCtD
Sibutramine—Hypoaesthesia—Octreotide—thymus cancer	0.00394	0.00394	CcSEcCtD
Sibutramine—Pharyngitis—Octreotide—thymus cancer	0.00393	0.00393	CcSEcCtD
Sibutramine—Oedema peripheral—Octreotide—thymus cancer	0.0039	0.0039	CcSEcCtD
Sibutramine—Visual impairment—Octreotide—thymus cancer	0.00382	0.00382	CcSEcCtD
Sibutramine—Tinnitus—Octreotide—thymus cancer	0.00369	0.00369	CcSEcCtD
Sibutramine—Immune system disorder—Octreotide—thymus cancer	0.00358	0.00358	CcSEcCtD
Sibutramine—Arrhythmia—Octreotide—thymus cancer	0.00354	0.00354	CcSEcCtD
Sibutramine—Alopecia—Octreotide—thymus cancer	0.0035	0.0035	CcSEcCtD
Sibutramine—Malnutrition—Octreotide—thymus cancer	0.00345	0.00345	CcSEcCtD
Sibutramine—Flatulence—Octreotide—thymus cancer	0.0034	0.0034	CcSEcCtD
Sibutramine—Tension—Octreotide—thymus cancer	0.00338	0.00338	CcSEcCtD
Sibutramine—Nervousness—Octreotide—thymus cancer	0.00335	0.00335	CcSEcCtD
Sibutramine—Back pain—Octreotide—thymus cancer	0.00334	0.00334	CcSEcCtD
Sibutramine—Muscle spasms—Octreotide—thymus cancer	0.00332	0.00332	CcSEcCtD
Sibutramine—Vision blurred—Octreotide—thymus cancer	0.00325	0.00325	CcSEcCtD
Sibutramine—Tremor—Octreotide—thymus cancer	0.00323	0.00323	CcSEcCtD
Sibutramine—Ill-defined disorder—Octreotide—thymus cancer	0.0032	0.0032	CcSEcCtD
Sibutramine—Anaemia—Octreotide—thymus cancer	0.00319	0.00319	CcSEcCtD
Sibutramine—Agitation—Octreotide—thymus cancer	0.00317	0.00317	CcSEcCtD
Sibutramine—Malaise—Octreotide—thymus cancer	0.00311	0.00311	CcSEcCtD
Sibutramine—Vertigo—Octreotide—thymus cancer	0.0031	0.0031	CcSEcCtD
Sibutramine—Syncope—Octreotide—thymus cancer	0.00309	0.00309	CcSEcCtD
Sibutramine—Palpitations—Octreotide—thymus cancer	0.00305	0.00305	CcSEcCtD
Sibutramine—Loss of consciousness—Octreotide—thymus cancer	0.00303	0.00303	CcSEcCtD
Sibutramine—Cough—Octreotide—thymus cancer	0.00301	0.00301	CcSEcCtD
Sibutramine—Convulsion—Octreotide—thymus cancer	0.00299	0.00299	CcSEcCtD
Sibutramine—Hypertension—Octreotide—thymus cancer	0.00298	0.00298	CcSEcCtD
Sibutramine—Myalgia—Octreotide—thymus cancer	0.00294	0.00294	CcSEcCtD
Sibutramine—Chest pain—Octreotide—thymus cancer	0.00294	0.00294	CcSEcCtD
Sibutramine—Arthralgia—Octreotide—thymus cancer	0.00294	0.00294	CcSEcCtD
Sibutramine—Anxiety—Octreotide—thymus cancer	0.00293	0.00293	CcSEcCtD
Sibutramine—Discomfort—Octreotide—thymus cancer	0.0029	0.0029	CcSEcCtD
Sibutramine—Dry mouth—Octreotide—thymus cancer	0.00287	0.00287	CcSEcCtD
Sibutramine—Oedema—Octreotide—thymus cancer	0.00281	0.00281	CcSEcCtD
Sibutramine—Anaphylactic shock—Octreotide—thymus cancer	0.00281	0.00281	CcSEcCtD
Sibutramine—Infection—Octreotide—thymus cancer	0.0028	0.0028	CcSEcCtD
Sibutramine—Shock—Octreotide—thymus cancer	0.00277	0.00277	CcSEcCtD
Sibutramine—Thrombocytopenia—Octreotide—thymus cancer	0.00276	0.00276	CcSEcCtD
Sibutramine—Tachycardia—Octreotide—thymus cancer	0.00275	0.00275	CcSEcCtD
Sibutramine—Skin disorder—Octreotide—thymus cancer	0.00273	0.00273	CcSEcCtD
Sibutramine—Hyperhidrosis—Octreotide—thymus cancer	0.00272	0.00272	CcSEcCtD
Sibutramine—Anorexia—Octreotide—thymus cancer	0.00268	0.00268	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00256	0.00256	CcSEcCtD
Sibutramine—Insomnia—Octreotide—thymus cancer	0.00255	0.00255	CcSEcCtD
Sibutramine—Paraesthesia—Octreotide—thymus cancer	0.00253	0.00253	CcSEcCtD
Sibutramine—Dyspnoea—Octreotide—thymus cancer	0.00251	0.00251	CcSEcCtD
Sibutramine—Somnolence—Octreotide—thymus cancer	0.0025	0.0025	CcSEcCtD
Sibutramine—Dyspepsia—Octreotide—thymus cancer	0.00248	0.00248	CcSEcCtD
Sibutramine—Decreased appetite—Octreotide—thymus cancer	0.00245	0.00245	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00243	0.00243	CcSEcCtD
Sibutramine—Constipation—Octreotide—thymus cancer	0.00241	0.00241	CcSEcCtD
Sibutramine—Pain—Octreotide—thymus cancer	0.00241	0.00241	CcSEcCtD
Sibutramine—Feeling abnormal—Octreotide—thymus cancer	0.00232	0.00232	CcSEcCtD
Sibutramine—Gastrointestinal pain—Octreotide—thymus cancer	0.0023	0.0023	CcSEcCtD
Sibutramine—Urticaria—Octreotide—thymus cancer	0.00224	0.00224	CcSEcCtD
Sibutramine—Abdominal pain—Octreotide—thymus cancer	0.00223	0.00223	CcSEcCtD
Sibutramine—Body temperature increased—Octreotide—thymus cancer	0.00223	0.00223	CcSEcCtD
Sibutramine—Hypersensitivity—Octreotide—thymus cancer	0.00207	0.00207	CcSEcCtD
Sibutramine—Asthenia—Octreotide—thymus cancer	0.00202	0.00202	CcSEcCtD
Sibutramine—Pruritus—Octreotide—thymus cancer	0.00199	0.00199	CcSEcCtD
Sibutramine—Diarrhoea—Octreotide—thymus cancer	0.00193	0.00193	CcSEcCtD
Sibutramine—Dizziness—Octreotide—thymus cancer	0.00186	0.00186	CcSEcCtD
Sibutramine—Vomiting—Octreotide—thymus cancer	0.00179	0.00179	CcSEcCtD
Sibutramine—Rash—Octreotide—thymus cancer	0.00177	0.00177	CcSEcCtD
Sibutramine—Dermatitis—Octreotide—thymus cancer	0.00177	0.00177	CcSEcCtD
Sibutramine—Headache—Octreotide—thymus cancer	0.00176	0.00176	CcSEcCtD
Sibutramine—Nausea—Octreotide—thymus cancer	0.00167	0.00167	CcSEcCtD
